Hey guys, the Remote Design Sprint is over, it was an incredible week. Thanks again to you all for participating and making this happen, together we were able to crunch several months of work into only one week and are now able to work with the results. Before I go into the user feedback, here is what we have been working on so far:

Quick Recap


Based on the collaboration in Miro we were able to create individual concepts and merge them into one beautiful storyboard:

https://s3-us-west-2.amazonaws.com/secure.notion-static.com/9ae51fa8-5ea7-4332-8dff-20866bcedd10/Molecule_Sprint_(2).jpg

This was a perfect and precise basis for us to power through the weekend and create the visual interface design for the prototype, which you can access here:

https://www.figma.com/file/eK7eXG0E2IZGvgu5KvaJzFYr/Molecule-Master?node-id=0%3A1

This prototype was shown to 3 people in total:

Long Term Goal

"In two years time, Molecule will be the most effective way IP creators and investors can collaborate on the best pharmaceutical products."

Overall, the concept is definitely going in the correct direction. Everyone was excited about the idea and wanted to see it become reality. A few changes should be made considering the appropriate level of detail and interests of individual stakeholders, but all in all we're on the right path.

Sprint Questions

Let's see how our prototype solved the Sprint Questions:

  1. Can we impress (our) investors? (Top question)

    The concept seemed to be very easy to understand for investors and all testers appreciated the look and feel of it. Visually, it just needs to be a little clearer - the bubble overview/statistic needs to be more understandable, the project tiles need to use more human-readable language ("bounty" is not an accepted term either) and ideally, the dashboard should focus on showing a personalized overview. Filling out the IP does not seem as important to see for investors and overall might be a good idea to separate the investment part from the IP creation part (similar to AirBnB).

  2. Can we create trust and credibility between ourselves and the most important stakeholders groups in order to achieve adoption?

    One of the biggest problems with trusting the IP registration is the lack of explanation and how registration applies to real world patent registration. One tester suggested breaking apart the the investment part of the platform and the IP registration, since the former is very simple and "easy going", whereas registering intellectual property is a more serious process.

    For investors, the most important factors are quality control and understanding the exact area the projects are focused on. Who worked on what, related patents, exact financial needs for milestones could additionally help making a decision on what to invest in.

    Apart from those two stakeholders, it's worth mentioning that the current pharma industry and manufacturing companies are also part of the progress. For them, registering IP might be much more important (especially financially) than to academic research groups, who might not be interested in protecting IP.